Skip to the comparison

Independent review

PeterMD review: GLP‑1 pricing and terms

3.1/5

Trustpilot, on 8 reviews only · read 12 Aug 2026

What you pay

$747 at this rate ÷ 3 months

$249/mo

billed as a term, not monthly

✓ Verified 6 Oct 2026

First year

$2,988 at this dose; higher doses have no published price

Cancellation

Published terms are unclear

PeterMD's own site, not a paid placement

The price receipt

What makes up the total

Medication / month of the term
$249
Membership / month
Not recorded
Term total, medication only
$747

3-month plan, $747 at this rate

See the calculation

$747 ÷ 3 = $249/mo

Price verified ✓ Price checked

7.9/10 VerifiedDose score How we score this →

What PeterMD charges, read from its own pages on 6 Oct 2026.

What stands out

  • Dose pricing Dose schedule not recorded
  • Insurance Insurance filing not recorded
  • Regulatory record Nothing found in our search
  • Legal entity Legal entity not recorded
  • Cancellation Cancellation terms not published
  • Price condition 3-month plan, $747 at this rate

PeterMD sells a GLP-1 with B12 and does not name the molecule. It prints a monthly rate and a total on each card and never says how long the term is, and its own billing policy says the interval is described at checkout.

Verdict: We would not start here. PeterMD prints a monthly rate and a total on each GLP-1 card and never states the term either figure buys, and its own policy defers that to checkout. The one plan whose term it states in words is the tirzepatide. Its two cheaper cards are not prices you can compare with anybody.

  • States the billing term in words for its tirzepatide plan, which is the one price here we could verify.
  • Prints a total beside the monthly rate on both GLP-1 cards, so each card at least shows a sum rather than a rate on its own.
  • No FDA action turned up under the brand name.

Quick facts

Medications
GLP1 + B12, Tirzepatide
Regulatory record
No actions on record
Price history

Pricing, verified at checkout

Price changes appear in the change log.

PeterMD plans. 3 plans, monthly cash price with the date each price was verified.
Plan Medication Price / month What's included
GLP1 + B12, Level 2, current/returning users, est. 8-12 week supply Molecule not named Compounded $139 advertised $834 total published Billing term not stated, so this is not comparable Figure read Not stated by the provider
GLP1 + B12, Level 1, first-time users, est. 10-12 week supply Molecule not named Compounded $149 advertised $447 total published Billing term not stated, so this is not comparable Figure read Same as above
Tirzepatide, 60mg vial, billed quarterly Injection Compounded $249 3-month plan, $747 at this rate Price verified ✓ Price checked Same as above

HSA/FSA accepted where the provider states it; we have not established whether insurance is billed.

Where it falls short

The missing fact here is the term. PeterMD prints a monthly rate and a total on each of its GLP-1 cards, and nowhere on the page does it say how many months either figure buys. Its own billing policy answers the question by deferring it: the charging interval is described at checkout, which means a reader cannot know what they are agreeing to until they are most of the way to agreeing to it. That is why the two cheaper cards sit on this page as advertised figures rather than as prices, and it is why the older puzzle on the returning-customer card cannot be settled either. That card states a rate, a total and a number of weeks of supply that do not reconcile, and with no term published there is nothing to check them against. Two more gaps. It names no molecule for the product, and we have not established the cancellation route.

  • Neither GLP-1 card states a billing term. PeterMD prints a monthly rate and a total, and its own billing policy says the charging interval is described at checkout.
  • Names no molecule for the GLP-1 it sells. The card calls it a GLP-1 with B12, so what you would be taking is not stated on the page.
  • On the returning-customer card the monthly rate, the total and the stated weeks of supply do not reconcile, and with no term stated there is nothing to check them against.
  • Tiers its GLP-1 by whether you are a new or a returning customer rather than by dose, so nothing here tells you what a higher dose costs.
  • The only price we could verify is billed quarterly, so there is no month-to-month route on this page.
  • We could not establish whether PeterMD bills anything on top of the plan price, so that row reads not published. A fee we have not verified is not a fee of zero.
  • On tirzepatide it advertises a lower first payment and a higher standing rate. This page carries the standing rate.
  • The independent review profile we found holds too few reviews for us to publish a score. PeterMD's own site displays a rating and names no source behind it.
  • The terms we read on 23 August 2026 identify the contracting party only as PeterMD, with an address and a governing-law state. They name no corporate entity for the provider itself.
  • We have not established the cancellation route, and we have read these prices once, on one day.

How PeterMD compares

PeterMD compared with 2 alternative providers.
Metric
VerifiedDose score 7.9 9.3 7.9
From / month checked the same day for all 3 $249 3-month plan, $747 at this rate Price verified ✓ Price checked $99 Price verified ✓ Price checked $149 Price verified ✓ Price checked
Insurance Not recorded Not recordedFiles claims

More columns to the right. Drag or swipe the table.

How it works

PeterMD terms: what the provider states about its model, timing, insurance and cancellation.

Model
Compounded (legacy)
Membership fee
Not published
Insurance
Not recorded
Time to a prescription decision
Not stated
Cancellation
Not documented
States served
Not published
VerifiedDose score
7.9/10. How we rate providers.

What customers say

Third-party aggregate, quoted not endorsed

8reviews on Trustpilot, read 12 Aug 2026

Too small a base to average: below about a hundred reviews a handful of entries moves the score a full point, so we report how many people have written and leave the average unpublished.

See the profile on Trustpilot (opens in a new tab)

Evidence and company record

As of 21 Aug 2026, prices are checked by manual check. Third-party reputation: 8 Trustpilot reviews, too few to publish an average. Official domain: https://getpetermd.com/.

Regulatory record

Regulatory record No regulatory flags on file for PeterMD. last checked 21 Aug 2026 Checked: FDA warning letters, federal court dockets, state medical board actions.

What has changed

  • Payment terms clarified

    PeterMD billed every 6 months → term not established

    Observation and source

    Recorded here on 21 Aug 2026. This entry predates our observation log, so the day the provider's page changed is not on file.

    Correction to our record, not a change at PeterMD.

    The page this was read from (opens in a new tab)
  • Monthly price published again

    PeterMD not published → $139

    Observation and source

    Seen on the provider's own page on 12 Aug 2026, recorded here on 13 Aug 2026.

    GLP-1 (molecule not published) — verified 12 Aug 2026

    The page this was read from (opens in a new tab)
  • Monthly price published again

    PeterMD not published → $149

    Observation and source

    Seen on the provider's own page on 12 Aug 2026, recorded here on 13 Aug 2026.

    GLP-1 (molecule not published) — verified 12 Aug 2026

    The page this was read from (opens in a new tab)
  • Monthly price published again

    PeterMD not published → $249

    Observation and source

    Seen on the provider's own page on 12 Aug 2026, recorded here on 13 Aug 2026.

    Tirzepatide — verified 12 Aug 2026

    The page this was read from (opens in a new tab)

The term is the fact PeterMD does not publish

We looked for a billing term in three places and found it in none. The product page prints a monthly rate and a total on each card and never says how long either covers. The terms and conditions run to twenty-six sections and do not mention billing, renewal or price. The refund and auto-bill policy comes closest, and what it says is that the payment method is charged at regular intervals as described during checkout. So the interval exists and PeterMD knows it, and the place it is disclosed is inside the purchase flow. We stop before entering a purchase flow, so we cannot tell you what it is. That is why two of the three cards on this page carry a figure and no price, and it is a stronger finding than silence would have been: the provider has told us where the answer is kept.

Questions readers ask

What is PeterMD's billing term?

It does not publish one. Its product page prints a monthly rate and a total with no term attached, its terms and conditions do not mention billing, and its refund policy says the interval is described at checkout. We stop before checkout, so this page states the figures and not the term.

Does PeterMD charge a membership fee?

We could not establish that. Its product pages show no membership line, and a fee we have not verified is not a fee of zero, so the fee row on this page reads not published.

Why is there no customer rating for PeterMD on this page?

The independent profile we found holds too few reviews for a score we would stand behind, so we publish none. PeterMD's own site displays a rating and does not name the source behind it.

Can I buy a single month from PeterMD?

Not at a price we could verify. The one plan whose term it states is billed quarterly, and its two cheaper cards state no term at all, so neither is a monthly price.

Which GLP-1 does PeterMD sell?

Its card names a GLP-1 with B12 and no molecule. We used to print semaglutide against these rows, which was our inference rather than its disclosure, and we have taken it out.

Where it prescribes

No state coverage on file for PeterMD. Nothing published

Sources

  • PeterMD public checkout and terms of service, verified 6 Oct 2026

How this site works

How we rate providers

Verified price, first-year cost, availability, speed to prescription, cancellation terms, regulatory record. Methodology.

No clinical review

We are not clinicians and this page carries no clinical review. Drug and regulatory facts are cited directly from FDA, CMS and court records.

How we make money

We may earn a referral fee from links on this page. Fees never influence ratings. Full disclosure.